(Total Views: 142)
Posted On: 10/26/2020 11:50:46 AM
Post# of 85638

$GLYC News Article - New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) Meeting https://marketwirenews.com/news-releases/new-...55921.html


My Twitter: WhyteStocks